Replies to post #178925 on Vivos Inc (RDGL)

[LeAcc]

I have so many of them on ignore here … that individual in particular. I do enjoy popping in a bid here or there not only to purchase shares, but sometimes it’s just entertaining to see them scramble 🤣

[familyof5]

ASCM Market Maker Report in the Spotlight.....


Who got shares? Who's shares became unrestricted? Why did ASCM become so active starting in April?



August 2023
ASCM
ASCENDIANT CAPITAL MARKETS, LLC
0
DID NOT PARTICIPATE*
0%


September 20232
ASCM
ASCENDIANT CAPITAL MARKETS, LLC
0
DID NOT PARTICIPATE*
0%


October 2023
ASCM
ASCENDIANT CAPITAL MARKETS, LLC
0
DID NOT PARTICIPATE*
0%


November 2023
ASCM
ASCENDIANT CAPITAL MARKETS, LLC
0
DID NOT PARTICIPATE*
0%


December 2023
ASCM
ASCENDIANT CAPITAL MARKETS, LLC
1,263,938
RANKING ORDER 6
5.75%


January 2024
ASCM
ASCENDIANT CAPITAL MARKETS, LLC
0
DID NOT PARTICIPATE*
0%


February 2024
ASCM
ASCENDIANT CAPITAL MARKETS, LLC
0
DID NOT PARTICIPATE*
0%


March 2024
ASCM
ASCENDIANT CAPITAL MARKETS, LLC
0
DID NOT PARTICIPATE*
0%


April 2024
ASCM
ASCENDIANT CAPITAL MARKETS, LLC
3,417,551
RANKING ORDER 5
9.9%


May 2024
ASCM
ASCENDIANT CAPITAL MARKETS, LLC
1,930,349
RANKING ORDER 7
3.87%


June 2024
ASCM
ASCENDIANT CAPITAL MARKETS, LLC
2,046,662
RANKING ORDER 7
6.1%


July 2024
ASCM
ASCENDIANT CAPITAL MARKETS, LLC
5,796,143
RANKING ORDER 3
12.97%


August 2024
ASCM
ASCENDIANT CAPITAL MARKETS, LLC
TBD
RANKING ORDER TBD
% TBD


Here's where we stood as far as capital structure. No toxic debt or derivatives at the beginning of January 2022.....Dr. Korenko said so in January 2022


Vivos Inc. Provides 2021 Recap and Outlines 2022 ObjectivesPress Release | 01/24/2022
https://www.otcmarkets.com/stock/RDGL/news/Vivos-Inc-Provides-2021-Recap-and-Outlines-2022-Objectives?id=340332

"Our capital structure and balance sheet are in excellent shape, with no toxic debt or derivatives and all the historical notes repaid"

[familyof5]

Little game of Leap Frog going on with the BID. Dr. Korenko did state on the 29th of July WITHIN 45 days. We're now 24 days in. You can pay for them now. Or pay A LOT MORE for them later.....

JULY 29TH Press Release:

We are confident that thus far our submissions have provided 90-95% percent of the information they require and that Vivos will be able to resubmit the refined IDE application with high quality responses demonstrating a compelling risk/benefit analysis to the FDA within the next 45 days

August 16th Post X

Update from the CEO regarding the ongoing discussions with the FDA. General updates will be posted on this platform as new information becomes available. Subscribe to our newsletter at https://t.co/FfgSTxpyrZ for important press releases for #RadioGel and #IsoPet $RDGL pic.twitter.com/1t2fJ1hcnS

— Vivos Inc. (@VivosIncUSA) August 16, 2024